Loading...
Beyond cardiovascular medicine: potential future uses of icosapent ethyl
The REDUCE-IT trial demonstrated that icosapent ethyl, an ethyl ester of eicosapentaenoic acid (EPA), reduced cardiovascular events in an at-risk population by a substantial degree. While the cardiovascular protective properties of this compound are now proven, several other potential uses are being...
Na minha lista:
| Udgivet i: | Eur Heart J Suppl |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537800/ https://ncbi.nlm.nih.gov/pubmed/33061868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa119 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|